Kidney Disease

Researchers identified significant differences in eGFR and measured eGFR on an individual level, according to data published in Annals of Internal Medicine.

Among patients with autosomal dominant polycystic kidney disease, outcomes were strongly associated with race and ethnicity.

Fewer than one in 10 adults with type 2 diabetes in the U.S. use SGLT2 inhibitors or GLP-1 receptor agonists, and only SGLT2 inhibitors have seen an increase in use over the last decade, according to study findings.

The United States Preventive Services Task Force added screening for chronic kidney disease to its list of preventive services under active consideration, according to a press release.

Vera Therapeutics Inc. announced new data for its product candidate atacicept in two presentations at the European Renal Association Congress in France.

Bon Secours Mercy Health and Strive Health have entered a collaborative relationship to provide “high-quality, whole-person care” for patients with kidney disease.

Investor groups GuideWell and Highmark Ventures led a $35 million funding round for kidney population health management company Healthmap Solutions, according to a company press release.

Adults with type 2 diabetes who drink coffee had less decline in kidney function over time compared with non-coffee drinkers, according to study findings published in the Journal of Diabetes Investigation.

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Bob Nagy, vice-president of sales for AvoMD, discusses how its clinical decision support platform is making guidelines available at point-of-care.

Fresenius Medical Care has appointed Nwamaka “Amaka” Eneanya, MD, MPH, FASN, as head of strategy and operations for its global medical office.